| abstract |
The present invention relates to the use of a compound of formula (I) for the manufacture of a medicament for the treatment of a disease caused, for example, by an immunological disorder such as allergic rhinitis, allergic conjunctivitis, allergic asthma, atopic dermatitis, esophagus allergy, atopic eczema or rheumatoid arthritis. Lt; RTI ID = 0.0 > pharmaceutically < / RTI > acceptable salt thereof. In formula (I), R 1 is H or CH 3 ; R 2 is OCOCH 3 , ═O, or OH; R 3 is H or OH; R 4 is -C (= CH 2 ) -C (CH 3 ) 2 R a wherein R a is H or OH, or -CH═C (CH 3 ) R b where R b is CH 3 or CH 2 OH); R 5 is H or OH, and R 6 is CH 3 or CH 2 OH. |